Our mission is to accelerate oncology innovation into world changing impact
A new kind
of company
Founded in 2017 by a team motivated to increase the current success rates in oncology drug discovery and development, Cumulus Oncology is Europe’s first oncology biotech build company.
At Cumulus, we leverage our key resources across multiple companies, enhancing efficiency and spreading the risks associated with the historical biotech model. By strategically distributing efforts across multiple companies, each with their own Oncology focus, Cumulus maximises the impact and chances of successful outcomes across a number of companies and provides “multiple shots on goal”.
Fast, flexible
and efficient
Adaptable
- Company concepts – single asset vs portfolio approach
- Breadth – scientific expertise
- Resourcing – maximise staff and capital efficiency
- Staged funding to reach pre-identified value inflection points
Proactive
- Reduced risk across a portfolio – not one technology/modality
- Cherry picked projects
- Partnerships aligned with business goals
- Rapid decision-making with minimal cost
- Build portfolio mix across various stages
Meet our team
Unique mix of scientists and entrepreneurs
